» Articles » PMID: 30872566

Mass Spectrometry-based Proteome Profiling of Extracellular Vesicles and Their Roles in Cancer Biology

Overview
Journal Exp Mol Med
Date 2019 Mar 16
PMID 30872566
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

Over the past three decades, extracellular vesicles (EVs) have arisen as important mediators of intercellular communication that are involved in the transmission of biological signals between cells to regulate various biological processes. EVs are largely responsible for intercellular communication through the delivery of bioactive molecules, such as proteins, messenger RNAs (mRNAs), microRNAs (miRNAs), DNAs, lipids, and metabolites. EVs released from cancer cells play a significant role in signal transduction between cancer cells and the surrounding cells, which contributes to the formation of tumors and metastasis in the tumor microenvironment. In addition, EVs released from cancer cells migrate to blood vessels and flow into various biological fluids, including blood and urine. EVs and EV-loaded functional cargoes, including proteins and miRNAs, found in these biological fluids are important biomarkers for cancer diagnosis. Therefore, EV proteomics greatly contributes to the understanding of carcinogenesis and tumor progression and is critical for the development of biomarkers for the early diagnosis of cancer. To explore the potential use of EVs as a gateway to understanding cancer biology and to develop cancer biomarkers, we discuss the mass spectrometric identification and characterization of EV proteins from different cancers. Information provided in this review may help in understanding recent progress regarding EV biology and the potential roles of EVs as new noninvasive biomarkers and therapeutic targets.

Citing Articles

Congenital Zika Syndrome: Insights from Integrated Proteomic and Metabolomic Analysis.

Gomes-de-Pontes L, Barreiros L, Gomes L, Salgado R, da Silva Napoleao S, Soeiro-Pereira P Biomolecules. 2025; 15(1).

PMID: 39858427 PMC: 11762526. DOI: 10.3390/biom15010032.


Approaches and Challenges in Characterizing the Molecular Content of Extracellular Vesicles for Biomarker Discovery.

Kumari S, Lausted C, Scherler K, Ng A, Lu Y, Lee I Biomolecules. 2025; 14(12.

PMID: 39766306 PMC: 11674167. DOI: 10.3390/biom14121599.


Mucosal Exosome Proteomics of Hybrid Grouper ♀ × ♂ Infected by .

Yang D, Ma X, Zhong S, Guo J, Cheng D, Chen X Animals (Basel). 2024; 14(23).

PMID: 39682367 PMC: 11640173. DOI: 10.3390/ani14233401.


Exosome-based drug delivery systems for enhanced neurological therapeutics.

Vahab S, V V, Kumar V Drug Deliv Transl Res. 2024; 15(4):1121-1138.

PMID: 39325272 DOI: 10.1007/s13346-024-01710-x.


Optimized workflow of EV enrichment from human plasma samples for downstream mass spectrometry analysis.

Erwied P, Gu Y, Simon L, Schneider M, Helm D, Michel M Discov Oncol. 2024; 15(1):374.

PMID: 39190201 PMC: 11349724. DOI: 10.1007/s12672-024-01248-x.


References
1.
Perez-Hernandez D, Gutierrez-Vazquez C, Jorge I, Lopez-Martin S, Ursa A, Sanchez-Madrid F . The intracellular interactome of tetraspanin-enriched microdomains reveals their function as sorting machineries toward exosomes. J Biol Chem. 2013; 288(17):11649-61. PMC: 3636856. DOI: 10.1074/jbc.M112.445304. View

2.
Kahlert C, Kalluri R . Exosomes in tumor microenvironment influence cancer progression and metastasis. J Mol Med (Berl). 2013; 91(4):431-7. PMC: 4073669. DOI: 10.1007/s00109-013-1020-6. View

3.
Raposo G, Stoorvogel W . Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 2013; 200(4):373-83. PMC: 3575529. DOI: 10.1083/jcb.201211138. View

4.
Thery C, Ostrowski M, Segura E . Membrane vesicles as conveyors of immune responses. Nat Rev Immunol. 2009; 9(8):581-93. DOI: 10.1038/nri2567. View

5.
Gabrilovich D, Ostrand-Rosenberg S, Bronte V . Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol. 2012; 12(4):253-68. PMC: 3587148. DOI: 10.1038/nri3175. View